Go Pro
NASDAQ:OPTH

Optimi Health (OPTH) Stock Price, News & Analysis

$4.78 +0.08 (+1.70%)
As of 04:00 PM Eastern

About Optimi Health Stock (NASDAQ:OPTH)

Advanced

Key Stats

Today's Range
$4.70
$4.78
50-Day Range
$4.11
$5.15
52-Week Range
$4.00
$6.40
Volume
4,406 shs
Average Volume
24,554 shs
Market Capitalization
$27.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Reduce

Company Overview

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.

Optimi Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

OPTH MarketRank™: 

Optimi Health scored higher than 23% of companies evaluated by MarketBeat, and ranked 808th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Optimi Health has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Optimi Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Optimi Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Optimi Health are expected to grow in the coming year, from ($1.02) to ($0.46) per share.

  • Percentage of Shares Shorted

    0.31% of the float of Optimi Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Optimi Health has a short interest ratio ("days to cover") of 0.65, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Optimi Health has recently decreased by 14.89%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Optimi Health does not currently pay a dividend.

  • Dividend Growth

    Optimi Health does not have a long track record of dividend growth.

  • News Sentiment

    Optimi Health has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Optimi Health this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for OPTH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Optimi Health to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.
Receive OPTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OPTH Stock News Headlines

Optimi Health Corp OPTH
The ultimate IPO unicorn before Labor Day
Anthropic is now valued at over $1 trillion, more than every U.S. airline combined and larger than the U.S. defense budget. Its annualized revenue grew 80x in the first quarter, and an IPO could arrive as early as October. For a limited time, investors can access a report detailing how to explore a pre-IPO stake in Anthropic for $29, a 94% discount off the retail price. The package includes a year of Disruptors and Dominators, monthly stock ideas, and four special reports.tc pixel
Optimi Health Establishes Discretionary Equity Facility
Optimi Health Establishes Discretionary Equity Facility
See More Headlines

OPTH Stock Analysis - Frequently Asked Questions

Optimi Health's stock was trading at $6.08 on May 20, 2026. Since then, OPTH stock has decreased by 21.4% and is now trading at $4.78.

Optimi Health shares reverse split on the morning of Wednesday, May 20th 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 19th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Optimi Health (OPTH) raised $15 million in an initial public offering on Wednesday, May 20th 2026. The company issued 2,400,000 shares at $6.25 per share. Joseph Gunnar & Co. acted as the underwriter for the IPO.

Optimi Health's lock-up period expires on Monday, November 16th. Optimi Health had issued 2,400,000 shares in its IPO on May 20th. The total size of the offering was $15,000,000 based on an initial share price of $6.25. After the end of Optimi Health's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Shares of OPTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:OPTH
CIK
2027329
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
0.06
Quick Ratio
0.03

Sales & Book Value

Annual Sales
$290 thousand
Price / Sales
94.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
5,730,000
Free Float
N/A
Market Cap
$27.39 million
Optionable
N/A
Beta
N/A
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:OPTH) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners